{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T08:47:20Z","timestamp":1792572440098,"version":"4.5.0"},"reference-count":195,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2000,4,1]],"date-time":"2000-04-01T00:00:00Z","timestamp":954547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Critical Reviews in Oral Biology &amp; Medicine"],"published-print":{"date-parts":[[2000,4]]},"abstract":"<jats:p> The advent of the human immunodeficiency virus infection and the increasing prevalence of compromised individuals in the community due to modern therapeutic advances have resulted in a resurgence of opportunistic infections, including oral candidoses. One form of the latter presents classically as a white lesion of \"thrush\" and is usually easily diagnosed and cured. Nonetheless, a minority of these lesions appears in new guises such as erythematous candidosis, thereby confounding the unwary clinician and complicating its management. Despite the availability of several effective antimycotics for the treatment of oral candidoses, failure of therapy is not uncommon due to the unique environment of the oral cavity, where the flushing effect of saliva and the cleansing action of the oral musculature tend to reduce the drug concentration to sub-therapeutic levels. This problem has been partly circumvented by the introduction of the triazole agents, which initially appeared to be highly effective. However, an alarming increase of organisms resistant to the triazoles has been reported recently. In this review, an overview of clinical manifestations of oral candidoses and recent advances in antimycotic therapy is given, together with newer concepts, such as the post-antifungal effect (PAFE) and its possible therapeutic implications. <\/jats:p>","DOI":"10.1177\/10454411000110020301","type":"journal-article","created":{"date-parts":[[2009,1,9]],"date-time":"2009-01-09T00:40:32Z","timestamp":1231461632000},"page":"172-198","source":"Crossref","is-referenced-by-count":182,"title":["Oral Candidal Infections and Antimycotics"],"prefix":"10.1177","volume":"11","author":[{"given":"A.N.B.","family":"Ellepola","sequence":"first","affiliation":[{"name":"Division of Oral Bio-sciences, Faculty of Dentistry, University of Hong Kong, Prince Philip Dental Hospital, 34 Hospital Road, Hong Kong, Department of Oral Medicine, Faculty of Dental Sciences, University of Peradeniya, Peradeniya, Sri Lanka"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.P.","family":"Samaranayake","sequence":"additional","affiliation":[{"name":"Division of Oral Bio-sciences, Faculty of Dentistry, University of Hong Kong, Prince Philip Dental Hospital, 34 Hospital Road, Hong Kong,"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2000,4,1]]},"reference":[{"key":"atypb1","doi-asserted-by":"crossref","unstructured":"Abu-El Teen K., Ghannum M., Stretton RJ (1989). Effects of sub-inhibitory concentrations of antifungal agents on adherence of Candida spp. to buccal epithelial cells in vitro. Mycoses 32:551-562.","DOI":"10.1111\/j.1439-0507.1989.tb02180.x"},{"key":"atypb2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8628(19971031)72:3<253::AID-AJMG1>3.0.CO;2-S"},{"key":"atypb3","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/170.2.384"},{"key":"atypb4","doi-asserted-by":"crossref","unstructured":"Arendorf TM, Bredekamp B., Cloete CAC, Sauer G. (1998). Oral manifestations of HIV infection in 600 South African patients. J Oral Pathol Med 27:176-179.","DOI":"10.1111\/j.1600-0714.1998.tb01936.x"},{"key":"atypb5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2842.1995.tb00786.x"},{"key":"atypb6","doi-asserted-by":"crossref","unstructured":"Ariyaratnam S., Thakker NS, Sloan P., Thornhill MH (1997). Drug points: potentiation of warfarin anticoagulant activity by miconazole oral gel. Br Med J 314:349.","DOI":"10.1136\/bmj.314.7077.349a"},{"key":"atypb7","doi-asserted-by":"publisher","DOI":"10.1016\/0732-8893(96)00012-0"},{"key":"atypb8","doi-asserted-by":"publisher","DOI":"10.1177\/00220345920710060601"},{"key":"atypb9","doi-asserted-by":"publisher","DOI":"10.1016\/S1079-2104(97)90049-4"},{"key":"atypb10","doi-asserted-by":"crossref","unstructured":"Baciewicz AM, Menke JJ, Bokar JA, Baub EB ( 1994). Fluconazole-warfarin interaction. Ann Pharmacother 28:1111.","DOI":"10.1177\/106002809402800922"},{"key":"atypb11","unstructured":"Banting DW, Greenhorn PA, McMinn JG (1995). Effectiveness of a topical antifungal regimen for the treatment of oral candidiasis in older, chronically ill, institutionalized, adults. J Can Dent Assoc 61:199-200, 203-205."},{"key":"atypb12","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.38.7.1530"},{"key":"atypb13","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/21.3.561"},{"key":"atypb14","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.40.5.1317"},{"key":"atypb15","doi-asserted-by":"publisher","DOI":"10.1016\/0030-4220(89)90354-X"},{"key":"atypb16","doi-asserted-by":"publisher","DOI":"10.1016\/S1079-2104(96)80352-0"},{"key":"atypb17","doi-asserted-by":"publisher","DOI":"10.1016\/0030-4220(93)90290-K"},{"key":"atypb18","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(90)70256-H"},{"key":"atypb19","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)90793-9"},{"key":"atypb20","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.55.647.687"},{"key":"atypb21","doi-asserted-by":"publisher","DOI":"10.1159\/000239453"},{"key":"atypb22","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.19.1.199"},{"key":"atypb23","unstructured":"Brenciaglia MI, Ghezzi MC, Cipriani P., Mancini C., Trancassini M. (1986). The influence of antifungal drugs on adhesion of C. albicans to buccal epithelial cells. Chemotherapy 5:200-203."},{"key":"atypb24","unstructured":"Budtz-J\u00f8rgensen E. (1990). Candida-associated denture stomatitis and angular cheilitis. In: Oral candidosis. Samaranayake LP, MacFarlane TW, editors. London: Wright, pp. 156-183."},{"key":"atypb25","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0528.1975.tb00291.x"},{"key":"atypb26","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199702000-00005"},{"key":"atypb27","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199407000-00011"},{"key":"atypb28","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.40.2.419"},{"key":"atypb29","unstructured":"Craig WA, Gudmundsson S. (1996). The postantibiotic effect. In: Antibiotics in laboratory medicine. Lorian V, editor. Baltimore: Williams & Wilkins, pp. 296-329."},{"key":"atypb30","doi-asserted-by":"publisher","DOI":"10.1007\/BF01709586"},{"key":"atypb31","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0714.1991.tb00881.x"},{"key":"atypb32","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0714.1994.tb01100.x"},{"key":"atypb33","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0714.1997.tb01229.x"},{"key":"atypb34","doi-asserted-by":"publisher","DOI":"10.1080\/02681219480000511"},{"key":"atypb35","doi-asserted-by":"crossref","unstructured":"Dias AP, Samaranayake LP (1995). Clinical, microbiological and ultrastructural features of angular cheilitis lesions in Southern Chinese. Oral Dis 1:43-48.","DOI":"10.1111\/j.1601-0825.1995.tb00156.x"},{"key":"atypb36","doi-asserted-by":"publisher","DOI":"10.1007\/s007840050008"},{"key":"atypb37","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bdj.4803045"},{"key":"atypb38","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199709000-00003"},{"key":"atypb39","doi-asserted-by":"publisher","DOI":"10.1080\/02681218880000081"},{"key":"atypb40","unstructured":"Dupont BF, Dromer F., Improvisi L. (1996). The problem of azole resistance in Candida. J Mycol Med 6:12-19."},{"key":"atypb41","doi-asserted-by":"publisher","DOI":"10.1111\/j.1439-0507.1996.tb00514.x"},{"key":"atypb42","doi-asserted-by":"crossref","unstructured":"Ellepola ANB, Samaranayake LP (1998a). The post antifungal effect (PAFE) of antimycotics on oral Candida albicans isolates and its impact on candidal adhesion. Oral Dis 4:260-267.","DOI":"10.1111\/j.1601-0825.1998.tb00290.x"},{"key":"atypb43","doi-asserted-by":"crossref","unstructured":"Ellepola ANB, Samaranayake LP (1998b). The effect of limited exposure to antifungal agents on the germ tube formation of oral Candida albicans. J Oral Pathol Med 27:213-219.","DOI":"10.1111\/j.1600-0714.1998.tb01944.x"},{"key":"atypb44","doi-asserted-by":"publisher","DOI":"10.1016\/S0003-9969(98)00064-8"},{"key":"atypb45","doi-asserted-by":"crossref","unstructured":"Ellepola ANB, Samaranayake LP (1998d). Adhesion of oral Candida albicans to human buccal epithelial cells following limited exposure to antifungal agents. J Oral Pathol Med 27:325-332.","DOI":"10.1111\/j.1600-0714.1998.tb01964.x"},{"key":"atypb46","doi-asserted-by":"publisher","DOI":"10.1016\/S0003-9969(98)00075-2"},{"key":"atypb47","doi-asserted-by":"publisher","DOI":"10.1080\/089106099435718"},{"key":"atypb48","doi-asserted-by":"crossref","unstructured":"Ellepola ANB, Samaranayake LP (1999b). The in vitro post antifungal effect of nystatin on Candida species of oral origin. I Oral Pathol Med 28:112-116.","DOI":"10.1111\/j.1600-0714.1999.tb02007.x"},{"key":"atypb49","doi-asserted-by":"publisher","DOI":"10.1016\/0030-4220(90)90265-T"},{"key":"atypb50","unstructured":"Ezsias A., Wojnarowska F., Juniper R. (1997). Topical use of miconazole antifungal oral gel on warfarinized patients: a word of caution. Dent Update (December):421-422."},{"key":"atypb51","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199105000-00007"},{"key":"atypb52","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.12.1.80"},{"key":"atypb53","doi-asserted-by":"publisher","DOI":"10.1080\/02681219680000341"},{"key":"atypb54","unstructured":"Finch RG, Snyder IS (1994). Antifungal drugs. In: Modern pharmacology. Craig CR, Stitzel RE, editors. Boston: Little, Brown, pp. 647-656."},{"key":"atypb55","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.40.7.1604"},{"key":"atypb56","doi-asserted-by":"publisher","DOI":"10.1177\/106002809502900102"},{"key":"atypb57","doi-asserted-by":"crossref","unstructured":"Franklin I., Elias E., Hirsch C. (1990). Fluconazole-induced jaundice. Lancet 336:565.","DOI":"10.1016\/0140-6736(90)92120-7"},{"key":"atypb58","unstructured":"Fromtling RA (1984). Imidazoles as medically important antifungal agents: an overview. Drugs of Today 20:325-349."},{"key":"atypb59","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199447050-00003"},{"key":"atypb60","doi-asserted-by":"publisher","DOI":"10.1902\/jop.1997.68.8.729"},{"key":"atypb61","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/20.1.77"},{"key":"atypb62","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199203263261301"},{"key":"atypb63","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1987.03400180087032"},{"key":"atypb64","doi-asserted-by":"publisher","DOI":"10.1016\/0022-3913(91)90294-7"},{"key":"atypb65","doi-asserted-by":"publisher","DOI":"10.1902\/jop.1995.66.1.30"},{"key":"atypb66","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(08)81268-6"},{"key":"atypb67","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/31.2.245"},{"key":"atypb68","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.39.9.2128"},{"key":"atypb69","doi-asserted-by":"crossref","unstructured":"Hay RJ (1990). Overview of studies of fluconazole in oropharyngeal candidiasis. Rev Infect Dis 3:S334-S337.","DOI":"10.1093\/clinids\/12.Supplement_3.S334"},{"key":"atypb70","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199603000-00004"},{"key":"atypb71","doi-asserted-by":"publisher","DOI":"10.1016\/0030-4220(83)90349-3"},{"key":"atypb72","doi-asserted-by":"crossref","unstructured":"lacopino A., Wathen W. (1992). Oral candidal infection and denture stomatitis: a comprehensive review. J Am Dent Assoc 123:46-51.","DOI":"10.14219\/jada.archive.1992.0023"},{"key":"atypb73","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/12.4.303"},{"key":"atypb74","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/35.1.103"},{"key":"atypb75","doi-asserted-by":"publisher","DOI":"10.1016\/0022-3913(92)90053-D"},{"key":"atypb76","doi-asserted-by":"crossref","unstructured":"Kelly SL, Lamb DC, Kelly DE, Loeffler J., Einsele H. (1996). Resistance to fluconazole and amphotericin B in C. albicans from AIDS patients. Lancet 348:1523-1524.","DOI":"10.1016\/S0140-6736(05)65949-1"},{"key":"atypb77","unstructured":"Kirkpatrick CH (1993). Chronic mucocutaneous candidiasis. In: Candidiasis: pathogenesis, diagnosis and treatment. Bodey GP, editor. New York: Raven Press Limited, pp. 167-183."},{"key":"atypb78","doi-asserted-by":"publisher","DOI":"10.1016\/S0966-842X(97)01108-6"},{"key":"atypb79","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.34.11.2267"},{"key":"atypb80","doi-asserted-by":"publisher","DOI":"10.1016\/0030-4220(94)90114-7"},{"key":"atypb81","doi-asserted-by":"publisher","DOI":"10.1016\/0030-4220(94)90059-0"},{"key":"atypb82","doi-asserted-by":"publisher","DOI":"10.1111\/j.1875-595X.1999.tb00505.x"},{"key":"atypb83","doi-asserted-by":"publisher","DOI":"10.1016\/0022-3913(94)90341-7"},{"key":"atypb84","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/24.2.124"},{"key":"atypb85","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.9.5682"},{"key":"atypb86","unstructured":"Lambert H., O'Grady FW (1992). Antifungal agents. In: Antibiotics and chemotherapy. Lambert H, O'Grady FW, editors. London: Churchill Livingstone, pp. 27-37."},{"key":"atypb87","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bdj.4806796"},{"key":"atypb88","unstructured":"Laufen H., Yeates RA, Zimmermann T., de Los Reyes C. (1995). Pharmacokinetic optimization of the treatment of oral candidiasis with fluconazole: studies with a suspension. Drugs Exp Clin Res XXI:23-28."},{"key":"atypb89","unstructured":"Laurence DR, Bennett PN, Brown MJ (1997). Chemotherapy of fungal infections. In: Clinical pharmacology. Laurence DR, Bennett PN, Brown MI, editors. UK: Churchill Livingstone, pp. 235-238."},{"key":"atypb90","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/23.3.649"},{"key":"atypb91","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.33.10.2732-2737.1995"},{"key":"atypb92","unstructured":"Lesse AJ (1995). Antifungal agents. In: Essentials of pharmacology. Smith CM, Reynard A, editors. Philadelphia: W.B. Saunders, pp. 404-411."},{"key":"atypb93","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.1996.d01-764.x"},{"key":"atypb94","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.10.3.477"},{"key":"atypb95","doi-asserted-by":"publisher","DOI":"10.1016\/0030-4220(91)90518-H"},{"key":"atypb96","doi-asserted-by":"publisher","DOI":"10.1097\/00042560-199608150-00005"},{"key":"atypb97","doi-asserted-by":"crossref","unstructured":"Macura AB (1988). The influence of some antifungal drugs on in vitro adherence of C. albicans to human buccal epithelial cells. Mycoses 31:71-76.","DOI":"10.1111\/j.1439-0507.1988.tb04433.x"},{"key":"atypb98","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/173.1.219"},{"key":"atypb99","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/24.1.28"},{"key":"atypb100","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.41.10.2229"},{"key":"atypb101","doi-asserted-by":"publisher","DOI":"10.1080\/02681218980000101"},{"key":"atypb102","unstructured":"Martin MV (1990). Antifungal agents. In: Oral candidosis. Samaranayake LP, MacFarlane TW, editors. London: Wright, pp. 238-255."},{"key":"atypb103","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bdj.4805814"},{"key":"atypb104","unstructured":"Martinez MA, Gutierrez MJ, Aller AI, Montero O., Morilla D., Bernal S., et al. (1997). In vitro susceptibility of itraconazole against fluconazole resistant and susceptible Candida spp. isolated from oral cavities of HIV infected patients. J Mycol Med 7:123-127."},{"key":"atypb105","doi-asserted-by":"crossref","unstructured":"Martins MD, Rex JH (1997). Fluconazole suspension for oropharyngeal candidiasis unresponsive to tablets. Ann Intern Med 126:332-333.","DOI":"10.7326\/0003-4819-126-4-199702150-00020"},{"key":"atypb106","doi-asserted-by":"publisher","DOI":"10.1099\/00222615-42-5-372"},{"key":"atypb107","doi-asserted-by":"publisher","DOI":"10.1099\/00222615-20-1-97"},{"key":"atypb108","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/17.5.575"},{"key":"atypb109","unstructured":"McGinnis MR, Rinaldi MG (1996). Antifungal drugs: mechanisms of action, drug resistance, susceptibility testing and assays of activity in biological fluids. In: Antibiotics in laboratory medicine. Lorian V, editor. Baltimore: Williams & Wilkins, pp. 176-211."},{"key":"atypb110","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bdj.4809214"},{"key":"atypb111","doi-asserted-by":"crossref","unstructured":"Minguez F., Chiu ML, Lima JE, Nique R., Prieto J. (1994). Activity of fluconazole: postantibiotic effect, effects of low concentrations and of pretreatment on the susceptibility of C. albicans to leukocytes. J Antimicrob Chemother 34:93-100.","DOI":"10.1093\/jac\/34.1.93"},{"key":"atypb112","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bdj.4809253"},{"key":"atypb113","unstructured":"National Committee for Clinical Laboratory Standards (1995). Reference method for broth dilution antifungal susceptibility testing of yeasts: tentative standards. NCCLS document M27-T. Villanova, PA: NCCLS."},{"key":"atypb114","unstructured":"Newton AV (1962). Denture sore mouth: a possible aetiology. Br Dent J 112:357-360."},{"key":"atypb115","doi-asserted-by":"publisher","DOI":"10.1016\/0163-4453(93)92707-4"},{"key":"atypb116","doi-asserted-by":"crossref","unstructured":"Nguyen MT, Weiss PJ, LaBarre RC, Miller LK, Oldfield EC, Wallace MR (1996). Orally administered amphotericin B in the treatment of oral candidiasis in HIV-infected patients caused by azole-resistant C. albicans. AIDS 10:1745-1747.","DOI":"10.1097\/00002030-199612000-00027"},{"key":"atypb117","doi-asserted-by":"publisher","DOI":"10.1016\/0003-9969(94)90026-4"},{"key":"atypb118","doi-asserted-by":"publisher","DOI":"10.1007\/BF01974614"},{"key":"atypb119","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0714.1994.tb01109.x"},{"key":"atypb120","unstructured":"Odds FC ( 1994). Candida and candidosis. A review and bibliography. London: Balli\u00e8re, Tindall."},{"key":"atypb121","doi-asserted-by":"crossref","unstructured":"Odds FC, Webster CE (1988). Effect of azole antifungals in vitro on host parasite interactions relevant to Candida infections. J Antimicrob Chemother 2:473-481.","DOI":"10.1093\/jac\/22.4.473"},{"key":"atypb122","unstructured":"Odman PA (1992). The effectiveness of an enzyme-containing denture cleanser. Quint Int 23:187-190."},{"key":"atypb123","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/39.1.71"},{"key":"atypb124","doi-asserted-by":"publisher","DOI":"10.1016\/0109-5641(91)90035-W"},{"key":"atypb125","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bdj.4809547"},{"key":"atypb126","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/22.Supplement_2.S89"},{"key":"atypb127","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/24.5.776"},{"key":"atypb128","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199610000-00009"},{"key":"atypb129","unstructured":"Pons V., Greenspan D., Debriun M. (1993). Therapy for oropharyngeal candidiasis in HIV-infected patients: a randomized, prospective multicenter study of oral fluconazole versus clotrimazole troches. I Acquir Immune Defic Syndr 6:1311-1316."},{"key":"atypb130","doi-asserted-by":"publisher","DOI":"10.1086\/513664"},{"key":"atypb131","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/34.5.613"},{"key":"atypb132","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2842.1985.tb00633.x"},{"key":"atypb133","doi-asserted-by":"publisher","DOI":"10.1099\/00222615-42-5-362"},{"key":"atypb134","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.35.9.2320-2324.1997"},{"key":"atypb135","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0714.1994.tb00085.x"},{"key":"atypb136","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0714.1997.tb01239.x"},{"key":"atypb137","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/174.4.821"},{"key":"atypb138","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.39.1.1"},{"key":"atypb139","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.39.1.40"},{"key":"atypb140","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/24.2.235"},{"key":"atypb141","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.32.9.2092-2098.1994"},{"key":"atypb142","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.41.3.575"},{"key":"atypb143","unstructured":"Samaranayake LP (1990). Host factors and oral candidosis. In: Oral candidosis. Samaranayake LP, MacFarlane TW, editors. London: Wright, pp. 66-103."},{"key":"atypb144","unstructured":"Samaranayake LP (1991). Superficial oral fungal infections. Curr Opin Dent 1:415-422."},{"key":"atypb145","unstructured":"Samaranayake LP (1996). Essential microbiology for dentistry. London: Churchill Livingstone."},{"key":"atypb146","unstructured":"Samaranayake LP (1997). C. krusei infections and fluconazole therapy. Hong Kong Med J 3:312-314."},{"key":"atypb147","doi-asserted-by":"publisher","DOI":"10.1016\/0169-409X(94)90032-9"},{"key":"atypb148","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0714.1989.tb01552.x"},{"key":"atypb149","unstructured":"Samaranayake LP, Lamey PJ (1988). Oral candidosis: clinicopathological aspects. Dent Update (July\/August):227-231."},{"key":"atypb150","doi-asserted-by":"publisher","DOI":"10.1016\/0030-4220(81)90312-1"},{"key":"atypb151","unstructured":"Samaranayake LP, MacFarlane TW (1990). Oral candidosis. London: Wright."},{"key":"atypb152","unstructured":"Samaranayake LP, Yaacob HB (1990). Classification of oral candidosis. In: Oral candidosis. Samaranayake LP, MacFarlane TW, editors. London: Wright, pp. 124-132."},{"key":"atypb153","doi-asserted-by":"publisher","DOI":"10.1099\/00222615-41-5-295"},{"key":"atypb154","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(94)90300-X"},{"key":"atypb155","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.39.11.2378"},{"key":"atypb156","doi-asserted-by":"crossref","unstructured":"Scalarone GM, Mikami Y., Kurita N., Yazawa K., Uno J., Miyaji M. (1991). In vitro comparative evaluations of the postantifungal effect: synergistic interaction between flucytosine and fluconazole against C. albicans. Mycoses 34:405-410.","DOI":"10.1111\/j.1439-0507.1991.tb00803.x"},{"key":"atypb157","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/29.2.129"},{"key":"atypb158","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0528.1997.tb00925.x"},{"key":"atypb159","doi-asserted-by":"publisher","DOI":"10.1111\/j.1754-4505.1992.tb00458.x"},{"key":"atypb160","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-126-9-199705010-00003"},{"key":"atypb161","doi-asserted-by":"publisher","DOI":"10.1177\/10454411940050020101"},{"key":"atypb162","doi-asserted-by":"publisher","DOI":"10.1111\/j.1601-0825.1997.tb00361.x"},{"key":"atypb163","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-302X.1997.tb00377.x"},{"key":"atypb164","unstructured":"Shaoxi W., Ningru G., Youhong H. (1996). Effects of systemic fluconazole therapy on in vitro adhesion of C. albicans to buccal epithelial cells and changes of the cell surface proteins of the epithelial cells. Chinese Med Sci J 11:45-48."},{"key":"atypb165","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.12.1.40"},{"key":"atypb166","doi-asserted-by":"publisher","DOI":"10.1016\/0732-8893(94)90012-4"},{"key":"atypb167","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/36.6.885"},{"key":"atypb168","doi-asserted-by":"publisher","DOI":"10.1007\/BF01967082"},{"key":"atypb169","doi-asserted-by":"publisher","DOI":"10.1016\/S1079-2104(96)80304-0"},{"key":"atypb170","doi-asserted-by":"crossref","unstructured":"Smith DE, Midgley J., Allan M., Connolly GM, Gazzard BG (1988). Itraconazole versus ketoconazole in the treatment of oral and esophageal candidosis in patients infected with HIV. AIDS 5:1367-1371.","DOI":"10.1097\/00002030-199111000-00014"},{"key":"atypb171","unstructured":"Soames JV, Southam JC (1993). Infections of the oral mucosa. In: Oral pathology. Soames IV, Southam JC, editors. New York: Oxford, pp. 185-191."},{"key":"atypb172","doi-asserted-by":"publisher","DOI":"10.1007\/BF02013902"},{"key":"atypb173","doi-asserted-by":"publisher","DOI":"10.1099\/13500872-141-7-1507"},{"key":"atypb174","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2842.1978.tb01210.x"},{"key":"atypb175","doi-asserted-by":"publisher","DOI":"10.1080\/02681218780000391"},{"key":"atypb176","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1988.tb40414.x"},{"key":"atypb177","doi-asserted-by":"publisher","DOI":"10.1111\/j.1601-0825.1997.tb00337.x"},{"key":"atypb178","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/34.1.83"},{"key":"atypb179","doi-asserted-by":"crossref","unstructured":"Van Cutsem J. (1994). Prophylaxis of Candida and Aspergillus infections with oral administration of itraconazole. Mycoses 37:243-248.","DOI":"10.1111\/j.1439-0507.1994.tb00420.x"},{"key":"atypb180","doi-asserted-by":"publisher","DOI":"10.1007\/BF01591361"},{"key":"atypb181","unstructured":"Varthalitis I., Meunier F. (1995). Prophylaxis of fungal infections. In: Bailliere's clinical infectious diseases. Meunier F, editor. London: Bailli\u00e8re, Tindall, pp. 157-177."},{"key":"atypb182","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/21.6.755"},{"key":"atypb183","unstructured":"Walker DM, Arendorf T. (1990). Candidal leucoplakia, chronic multifocal candidosis and median rhomboid glossitis. In: Oral candidosis. Samaranayake LP, MacFarlane TW, editors. London: Wright, pp. 184-199."},{"key":"atypb184","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0714.1991.tb00915.x"},{"key":"atypb185","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/28.suppl_B.27"},{"key":"atypb186","doi-asserted-by":"crossref","unstructured":"Weems JJ (1992). Candida parapsilosis: epidemiology, pathogenicity, clinical manifestations, and antimicrobial susceptibility. Clin Infect Dis 14:757-766.","DOI":"10.1093\/clinids\/14.3.756"},{"key":"atypb187","doi-asserted-by":"publisher","DOI":"10.1016\/0163-4453(92)91346-D"},{"key":"atypb188","doi-asserted-by":"publisher","DOI":"10.1097\/00001432-199310000-00002"},{"key":"atypb189","doi-asserted-by":"publisher","DOI":"10.1111\/j.1601-0825.1997.tb00336.x"},{"key":"atypb190","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.11.2.382"},{"key":"atypb191","doi-asserted-by":"publisher","DOI":"10.1111\/j.1439-0507.1996.tb00153.x"},{"key":"atypb192","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-118-7-199304010-00003"},{"key":"atypb193","doi-asserted-by":"publisher","DOI":"10.1099\/00222615-44-4-311"},{"key":"atypb194","doi-asserted-by":"publisher","DOI":"10.1016\/S0030-6665(20)30744-1"},{"key":"atypb195","doi-asserted-by":"crossref","unstructured":"Zhanel GG, Hoban DJ, Harding KM (1991). The postantibiotic effect: a review of in vitro and in vivo data. DICP Ann Pharmacother 25:153-163.","DOI":"10.1177\/106002809102500210"}],"container-title":["Critical Reviews in Oral Biology &amp; Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10454411000110020301","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10454411000110020301","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,29]],"date-time":"2024-09-29T17:51:16Z","timestamp":1727632276000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/10454411000110020301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,4]]},"references-count":195,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2000,4]]}},"alternative-id":["10.1177\/10454411000110020301"],"URL":"https:\/\/doi.org\/10.1177\/10454411000110020301","relation":{},"ISSN":["1045-4411","1544-1113"],"issn-type":[{"value":"1045-4411","type":"print"},{"value":"1544-1113","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,4]]}}}